Inventor · disambiguated record
Daigen Xu
Also filed as: XU DAIGEN
7 granted patents·4 pending applications·93 citations·filing 1997–2022
84Inventor score
Top patents by PatentIndex Score
11 records- 0195US9346872B2Interleukin-10 fusion proteinsROCHE GLYCART AG·Filed 2013·Granted May 24, 2016·43 cites·22 claims
- 0288US10040843B2Interleukin-10 fusion proteins and uses thereofROCHE GLYCART AG·Filed 2016·Granted Aug 7, 2018·7 cites·22 claims
- 0384US6709866B2Methods for enhancing survival of a neuronAEGERA THERAPEUTICS INC·Filed 2000·Granted Mar 23, 2004·16 cites·19 claims
- 0476US11485786B2Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2019·Granted Nov 1, 2022·1 cites·15 claims
- 0571US12054549B2Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2022·Granted Aug 6, 2024·0 cites·9 claims
- 0668US6159948ATherapeutic and drug screening methods for the treatment and prevention of neuronal diseaseUNIV OTTAWA·Filed 1997·Granted Dec 12, 2000·26 cites·18 claims
- 0753US2001021699A1Therapeutic and drug screening methods for the treatment and prevention of neuronal diseaseUNIV OTTAWA·Filed 2001·Application pending·0 cites
- 0848US10012650B2Assays for BTK inhibitorsMERCK PATENT GMBH·Filed 2015·Granted Jul 3, 2018·0 cites·4 claims
- 0947US2019144547A1Anti-alpha-v integrin antibody for the treatment of fibrosis and/or fibrotic disordersMERCK PATENT GMBH·Filed 2016·Application pending·0 cites
- 1042US2009192158A1Methods for Treating or Preventing NeoplasiasKARGMAN STACIA·Filed 2007·Application pending·0 cites
- 1133US2015218244A1Interleukin-10 fusion proteins and uses thereofHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daigen Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →